Scientists have identified a new anti-ageing drug class that works by acting on a key gut bacteria process, an advance that ...
The presence of an operational classification of drug interactions (ORCA) class 3 or 4 drug-drug interactions (DDIs) did not increase the risk for colchicine-related gastrointestinal adverse events or ...
Latham & Watkins represented drugmaker Ardelyx Inc. in a lawsuit against the U.S. Department of Health and Human Services. U.S. District Senior Judge Beryl A. Howell dismissed the complaint on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback